Hua Ruishengyin, a shareholder of Hengan Biological (688238.SH) and its concerted actors, plans to reduce their shareholding by no more than 1%.

Zhtng Cijng APP News, Helovision Biotech (688238.SH) announced that the company's shareholder, Huaruishengyin and its concerted action person, plan to reduce their holdings of the company's shares through centralized bidding and block trading, with the total number of shares to be reduced not exceeding 6,490,400 shares, accounting for no more than 1% of the company's total share capital.